Skip to Main Content

Paper Details

Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection.
bioRxiv
6
2021
COVID-19, Molnupirivir, Pyrimidine, Remdesivir, SARS, SARS-, SARS-CoV-2, human, human respiratory cells, nucleoside, nucleoside triphosphates, pyrimidine, viral infections

Datasets